Journal of Tuberculosis and Lung Disease ›› 2024, Vol. 5 ›› Issue (5): 445-452.doi: 10.19983/j.issn.2096-8493.2024098
• Original Articles • Previous Articles Next Articles
Liu Weijian, Xu Yuxiang, Zhan Shenlin, Zhang Peize, Qin Hongjuan()
Received:
2024-05-30
Online:
2024-10-20
Published:
2024-10-14
Contact:
Qin Hongjuan
E-mail:qinhj2013@163.com
Supported by:
CLC Number:
Liu Weijian, Xu Yuxiang, Zhan Shenlin, Zhang Peize, Qin Hongjuan. Clinical characteristics of patients died of active tuberculosis with different ages in tuberculosis specialized hospital[J]. Journal of Tuberculosis and Lung Disease , 2024, 5(5): 445-452. doi: 10.19983/j.issn.2096-8493.2024098
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.2024098
特征 | 例数 | 构成比/百分 率(%) | 特征 | 例数 | 构成比/百分 率(%) |
---|---|---|---|---|---|
性别 | 住院次数 | ||||
男性 | 389 | 82.94 | 1 | 290 | 61.83 |
女性 | 80 | 17.06 | ≥2 | 179 | 38.17 |
年龄a | 合并症 | ||||
青年组 | 150 | 31.98 | 营养不良 | 185 | 39.45 |
中年组 | 111 | 23.67 | HIV感染 | 69 | 14.71 |
老年组 | 208 | 44.35 | 糖尿病 | 102 | 21.75 |
患者类型 | 心血管疾病 | 159 | 33.90 | ||
初治 | 425 | 90.62 | 慢性肺疾病 | 46 | 9.81 |
复治 | 44 | 9.38 | 肝衰竭 | 45 | 9.59 |
是否耐药 | 慢性肾脏病5期 | 44 | 9.38 | ||
是 | 17 | 3.62 | 中枢神经系统疾病 | 85 | 18.12 |
否 | 452 | 96.38 | 肿瘤性疾病 | 60 | 12.79 |
并发症 | 结缔组织疾病 | 21 | 4.48 | ||
感染性休克 | 94 | 20.04 | 血液系统疾病 | 15 | 3.20 |
肺部感染 | 358 | 76.33 | 结核感染部位 | ||
呼吸衰竭 | 243 | 51.81 | 仅肺结核 | 351 | 74.84 |
咯血 | 31 | 6.62 | 肺外结核 | 16 | 3.41 |
年份 | 多系统结核 | 102 | 21.75 | ||
2013 | 37 | 7.89 | 是否需机械通气 | ||
2014 | 43 | 9.17 | 是 | 100 | 21.32 |
2015 | 43 | 9.17 | 否 | 369 | 78.68 |
2016 | 44 | 9.39 | 是否流浪者 | ||
2017 | 54 | 11.51 | 是 | 16 | 3.41 |
2018 | 60 | 12.79 | 否 | 453 | 96.59 |
2019 | 50 | 10.66 | 是否发生粟粒性肺结核 | ||
2020 | 51 | 10.87 | 及结核性脑膜脑炎 | ||
2021 | 40 | 8.53 | 是 | 21 | 4.48 |
2022 | 47 | 10.02 | 否 | 448 | 95.52 |
特征 | 青年组(150例) | 中年组(111例) | 老年组(208例) | 统计检验值 | P值 | |||||
---|---|---|---|---|---|---|---|---|---|---|
性别[例(构成比,%)] | χ2=6.491 | 0.039 | ||||||||
男性 | 125(83.33) | 100(90.09) | 164(78.85) | |||||||
女性 | 25(16.67) | 11(9.91) | 44(21.15) | |||||||
住院天数[d,M(Q1,Q3)] | 6.0(2.0,16.5) | 10.0(2.0,23.0) | 10.0(4.3,21.5) | Z=4.304 | 0.116 | |||||
住院次数[例(构成比,%)] | χ2=2.444 | 0.295 | ||||||||
1 | 100(66.67) | 64(57.66) | 126(60.58) | |||||||
≥2 | 50(33.33) | 47(42.34) | 82(39.42) | |||||||
结核感染部位[例(构成比,%)] | ||||||||||
肺结核 | 93(62.00) | 83(74.77) | 175(84.13) | χ2=22.677 | <0.001 | |||||
肺外结核 | 7(4.67) | 7(6.31) | 2(0.97) | χ2=7.329 | 0.026 | |||||
多系统结核 | 50(33.33) | 21(18.92) | 31(14.90) | χ2=16.475 | <0.001 | |||||
年份[例(构成比,%)] | 0.051 | |||||||||
2013 | 16(10.67) | 7(6.31) | 14(6.73) | |||||||
2014 | 20(13.33) | 5(4.50) | 18(8.65) | |||||||
2015 | 16(10.67) | 10(9.01) | 17(8.17) | |||||||
2016 | 11(7.33) | 11(9.91) | 22(10.58) | |||||||
2017 | 19(12.67) | 11(9.91) | 24(11.54) | |||||||
2018 | 22(14.67) | 15(13.51) | 23(11.06) | |||||||
2019 | 11(7.33) | 14(12.61) | 25(12.02) | |||||||
2020 | 18(12.00) | 10(9.01) | 23(11.06) | |||||||
2021 | 8(5.33) | 18(16.22) | 14(6.73) | |||||||
2022 | 9(6.00) | 10(9.01) | 28(13.46) | |||||||
流浪者[例(构成比,%)] | 11(7.33) | 5(4.50) | 0(0.00) | χ2=14.751 | 0.001 | |||||
粟粒性肺结核及结核性脑膜脑炎[例(发生率,%)] | 10(6.67) | 5(4.50) | 6(2.88) | χ2=2.915 | 0.233 | |||||
耐药[例(发生率,%)] | 8(5.33) | 3(2.70) | 6(2.88) | χ2=1.850 | 0.397 | |||||
复治[例(发生率,%)] | 14(9.33) | 9(8.11) | 21(10.10) | χ2=0.337 | 0.854 | |||||
需要机械通气[例(发生率,%)] | 29(19.33) | 26(23.42) | 45(21.62) | χ2=0.658 | 0.720 |
合并症 | 青年组(150例) | 中年组(111例) | 老年组(208例) | χ2值 | P值 |
---|---|---|---|---|---|
营养不良 | 79(52.67) | 44(39.64) | 62(29.81) | 19.067 | <0.001 |
HIV感染 | 44(29.33) | 20(18.02) | 5(2.40) | 51.636 | <0.001 |
糖尿病 | 11(7.33) | 29(26.13) | 62(29.81) | 27.503 | <0.001 |
心血管疾病 | 14(9.33) | 25(22.52) | 120(57.69) | 99.355 | <0.001 |
慢性肺疾病 | 0(0.00) | 7(6.31) | 39(19.02) | 36.651 | <0.001 |
肝衰竭 | 11(7.33) | 19(17.12) | 15(7.21) | 9.487 | 0.009 |
慢性肾脏病5期 | 4(2.67) | 9(8.11) | 31(14.90) | 15.628 | <0.001 |
中枢神经系统疾病 | 17(11.33) | 18(16.22) | 50(24.04) | 9.837 | 0.007 |
肿瘤性疾病 | 4(2.67) | 18(16.22) | 38(18.27) | 20.544 | <0.001 |
结缔组织疾病 | 4(2.67) | 3(2.70) | 14(6.73) | 4.437 | 0.109 |
血液系统疾病 | 4(2.67) | 2(1.80) | 9(4.37) | 1.692 | 0.429 |
[1] | Chakaya J, Petersen E, Nantanda R, et al. The WHO Global Tuberculosis 2021 Report-not so good news and turning the tide back to End TB. Int J Infect Dis, 2022, 124 Suppl 1: S26-S29. doi:10.1016/j.ijid.2022.03.011. |
[2] | World Health Organization.Global tuberculosis report 2023. Geneva: World Health Organization, 2023. |
[3] |
Floyd K, Glaziou P, Houben R, et al. Global tuberculosis targets and milestones set for 2016—2035: definition and rationale. Int J Tuberc Lung Dis, 2018, 22(7): 723-730. doi:10.5588/ijtld.17.0835.
pmid: 29914597 |
[4] |
Furin J, Cox H, Pai M. Tuberculosis. Lancet, 2019, 393(10181): 1642-1656. doi:10.1016/s0140-6736(19)30308-3.
pmid: 30904262 |
[5] | Wen Y, Zhang Z, Li X, et al. Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China:a retrospective study. BMC Infect Dis, 2018, 18(1):104. doi:10.1186/s12879-018-3019-7. |
[6] | Tok PSK, Liew SM, Wong LP, et al. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study. PLoS One, 2020, 15(4):e0231986. doi:10.1371/journal.pone.0231986. |
[7] | World Health Organization. Framework for collaborative action on tuberculosis and comorbidities. Geneva: World Health Organization, 2022. |
[8] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[9] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09. |
[10] | World Health Organization.Global Tuberculosis Report 2021. Geneva: World Health Organization, 2021. |
[11] | 高磊, 张慧, 胡茂桂. 全国结核分枝杆菌潜伏感染率估算专家共识. 中国防痨杂志, 2022, 44 (1): 4-8. doi:10.19982/j.issn.1000-6621.20210662. |
[12] |
Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J, 2015, 45(4): 928-952. doi:10.1183/09031936.00214014.
pmid: 25792630 |
[13] |
Tankimovich M. Barriers to and interventions for improved tuberculosis detection and treatment among homeless and immigrant populations: a literature review. J Community Health Nurs, 2013, 30(2): 83-95. doi:10.1080/07370016.2013.778723.
pmid: 23659221 |
[14] |
Ranzani OT, Carvalho CR, Waldman EA, et al. The impact of being homeless on the unsuccessful outcome of treatment of pulmonary TB in São Paulo State, Brazil. BMC Med, 2016, 14: 41. doi:10.1186/s12916-016-0584-8.
pmid: 27006009 |
[15] | Scholze AR, Alves JD, Berra TZ, et al. Tuberculosis among People Living on the Street and Using Alcohol, Tobacco, and Illegal Drugs: Analysis of Territories in Extreme Vulnerability and Trends in Southern Brazil. Int J Environ Res Public Health, 2022, 19(13):7721. doi:10.3390/ijerph19137721. |
[16] | Chakaya J, Khan M, Ntoumi F, et al. Global Tuberculosis Report 2020-Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis, 2021, 113 Suppl 1(Suppl 1): S7-S12. doi:10.1016/j.ijid.2021.02.107. |
[17] | Shamebo T, Mekesha S, Getahun M, et al. Prevalence of pulmonary tuberculosis in homeless individuals in the Addis Ababa City, Ethiopia. Front Public Health, 2023, 11: 1128525. doi:10.3389/fpubh.2023.1128525. |
[18] | Gioseffi JR, Batista R, Brignol SM. Tuberculosis, vulnerabilities and HIV in homeless persons: a systematic review. Rev Saude Publica, 2022, 56:43. doi:10.11606/s1518-8787.2022056003964. |
[19] | 宋敏, 陆普选, 方伟军, 等. 2022年WHO全球结核病报告:全球与中国关键数据分析. 新发传染病电子杂志, 2023, 8(1):87-92. doi:10.19871/j.cnki.xfcrbzz.2023.01.018. |
[20] | Jones-López EC, Ayakaka I, Levin J, et al. Effectiveness of the standard WHO recommended retreatment regimen (category Ⅱ) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med, 2011, 8(3): e1000427. doi:10.1371/journal.pmed.1000427. |
[21] |
Patel KR, Patel A, Gadhiya NB. Risk Factors for Sputum Positive Pulmonary Tuberculosis Retreatment Cases and Factors Responsible for Treatment Outcome. J Assoc Physicians India, 2019, 67(8): 56-58.
pmid: 31562718 |
[22] | Ma JJ, Guo YJ, Li Z, et al. Prevalence and prognostic significance of malnutrition risk in patients with pulmonary tuberculosis: A hospital-based cohort study. Front Public Health, 2022, 10: 1039661. doi:10.3389/fpubh.2022.1039661. |
[23] |
Xu X, Zhu H, Cai L, et al. Malnutrition is Associated with an Increased Risk of Death in Hospitalized Patients with Active Pulmonary Tuberculosis: A Propensity Score Matched Retrospective Cohort Study. Infect Drug Resist, 2022, 15: 6155-6164. doi:10.2147/IDR.S382587.
pmid: 36304966 |
[24] | Sinha P, Ponnuraja C, Gupte N, et al. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis. Clin Infect Dis, 2023, 76(8): 1483-1491. doi:10.1093/cid/ciac915. |
[25] |
Ter Beek L, Alffenaar JC, Bolhuis MS, et al. Tuberculosis-Related Malnutrition: Public Health Implications. J Infect Dis, 2019, 220(2): 340-341. doi:10.1093/infdis/jiz091.
pmid: 30835281 |
[26] | Li A, Yuan SY, Li QG, et al. Prevalence and risk factors of malnutrition in patients with pulmonary tuberculosis: a systematic review and meta-analysis. Front Med (Lausanne), 2023, 10: 1173619. doi:10.3389/fmed.2023.1173619. |
[27] | Dos Santos DT, Arroyo LH, Alves YM, et al. Survival time among patients who were diagnosed with tuberculosis, the precocious deaths and associated factors in southern Brazil. Trop Med Health, 2021, 49(1): 31. doi:10.1186/s41182-021-00320-4. |
[28] | Montes K, Atluri H, Silvestre Tuch H, et al. Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting. J Clin Tuberc Other Mycobact Dis, 2021, 25: 100287. doi:10.1016/j.jctube.2021.100287. |
[29] | Gunda DW, Maganga SC, Nkandala I, et al. Prevalence and Risk Factors of Active TB among Adult HIV Patients Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study. Can J Infect Dis Med Microbiol, 2018, 2018: 1346104. doi:10.1155/2018/1346104. |
[30] | Alebel A, Demant D, Petrucka P, et al. Effects of undernutrition on opportunistic infections among adults living with HIV on ART in Northwest Ethiopia: Using inverse-probability weighting. PLoS One, 2022, 17(3): e0264843. doi:10.1371/journal.pone.0264843. |
[31] |
Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology, 2007, 120(4): 435-446. doi:10.1111/j.1365-2567.2007.02555.x.
pmid: 17313487 |
[32] | Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab, 2008, 93(7): 2737-2745. doi:10.1210/jc.2007-1972. |
[33] |
Dong Z, Shi J, Dorhoi A, et al. Hemostasis and Lipoprotein Indices Signify Exacerbated Lung Injury in TB With Diabetes Comorbidity. Chest, 2018, 153(5): 1187-1200. doi:10.1016/j.chest.2017.11.029.
pmid: 29224833 |
[34] | 王希江, 王森路, 赵珍, 等. 2010—2017年新疆维吾尔自治区涂阳肺结核患者流行病学特征分析. 结核病与肺部健康杂志, 2019, 8(3): 209-217. doi:10.3969/j.issn.2095-3755.2019.03.012. |
[35] | Lin CH, Lin CJ, Kuo YW, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis, 2014, 14: 5. doi:10.1186/1471-2334-14-5. |
[36] | 谭守勇, 袁园, 邝浩斌, 等. 中性粒细胞/淋巴细胞比值与2型糖尿病并发肺结核患者继发肺部感染相关性. 中国防痨杂志, 2021, 43(6): 602-605. doi:10.3969/j.issn.100-6621.2021.06.014. |
[37] |
Attia EF, Pho Y, Nhem S, et al. Tuberculosis and other bacterial co-infection in Cambodia: a single center retrospective cross-sectional study. BMC Pulm Med, 2019, 19(1): 60. doi:10.1186/s12890-019-0828-4.
pmid: 30866909 |
[38] |
Kalva SP. Bronchial artery embolization. Tech Vasc Interv Radiol, 2009, 12(2): 130-138. doi:10.1053/j.tvir.2009.08.006.
pmid: 19853230 |
[1] | Chen Yu, Li Xiaorui, Wang Miaoran, Zhang Yuqi, Liu Chang, Wang Zhaohua, Shi Jie, Fan Lichao, Yin Zhihua, Xie Jianping. The research progress on the role of metal ions in tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 102-112. |
[2] | Xu Yannan, Fang Zihao, Zhao Wenli, Zheng Jiaxiong, Liu Suyang, Lin Jianxiong, Ji Liwei, Chang Qiaocheng. Characterisation of isoniazid-resistant Mycobacterium tuberculosis mutations in China [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 14-21. |
[3] | Wan Ying, Pang Xuewen, Zhang Fan. Evaluation on effect of health promotion for tuberculosis prevention and control in Tianjin City from 2010 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 22-29. |
[4] | Zhao Yongnian, Zhang Lijie, Wang Tongmin. Analysis of the epidemiological characteristics of reported pulmonary tuberculosis in Xinjiang Production and Construction Corps, 2014—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 30-34. |
[5] | Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39. |
[6] | Yang Yan, Dong Wen, Chen Jianjun, Zhang Yu. Epidemiologic characteristics of pulmonary tuberculosis in Zhuxi County, Shiyan City (2014-2023) [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 40-45. |
[7] | Qi Wei, Zhao Enyi. The epidemic characteristics and the trends of pulmonary tuberculosis in elderly and non-elderly in central urban area, Tianjin from 2006 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 46-54. |
[8] | Yan Qinghu, Xue Feng, Yu Yong, Qin Yi, Yan Qingmei, Cui Jia. The value of ultrasound-guided microwave ablation in the treatment of localized tuberculous lesions [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 55-60. |
[9] | Chen Jing, Qin Yali, Wang Mingdong, Yang Rubin, Wang Qian, Peng Yanqing, Qiu Jiyao, Zhang Xiao, Zhou Xinai. The value of QuantiFERON-TB Gold Plus in the clinical diagnosis of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 61-67. |
[10] | Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72. |
[11] | Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78. |
[12] | Liao Ying, Pang Yan, Zhao Jing, He Gaoqin, You Maolin, Wang Lei. Analysis on the reporting and case finding delay characteristics of pulmonary tuberculosis patients in Liangping District, Chongqing from 2018 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 8-13. |
[13] | Zhang Ying, Guo Chunhui. Research progress in the treatment of tuberculous tracheobronchial stenosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 87-93. |
[14] | Yang Shuqi, Li Feng. Advances in PD1/PD-L1 inhibitors in tuberculosis research [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 94-101. |
[15] | Hu Xinyang, Gao Jingtao. Interpretation of WHO global tuberculosis report 2024 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 500-504. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||